(Q45917905)

English

Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers.

scientific article published in February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

0 references

Escherichia coli

1 reference

based on heuristic

inferred from title

author name string

Thai Hoa Joeres-Nguyen-Xuan

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

Stephan Karl Boehm

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

Lars Joeres

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

Juergen Schulze

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

Wolfgang Kruis

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

16

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

256-262

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

Probiotics: do they help to control intestinal inflammation?

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Relationships between human blood groups, bacterial pathogens, and urinary tract infections.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Bacteroides of the human lower intestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21042

21 January 2018

Identifiers

10.1002/IBD.21042

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19637333

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45917905&oldid=2125527488"